Nephrol Dial Transplant (2002) 17: 18-19
© 2002 European Renal Association-European Dialysis and Transplant Association
IV.2.6 Late recurrence of other diseases
GuidelinesA. In the rare case of recurrent lupus nephritis, no particular treatment is recommended. Only in the few patients with clinically evident flare up is a reinforcement of immunosuppression recommended.
(Evidence level C)
B. Recurrence of HenochSchönlein purpura may occur even in the absence of clinical signs and symptoms. The prognosis for the graft may be severe, particularly in adults.
(Evidence level C)
C. In the case of recurrent ANCA-associated renal or systemic vasculitis, it is recommended to reinforce the immunosuppression with appropriate agents.
(Evidence level C)
D. Since diabetic nephropathy recurs almost invariably after transplantation, strict control of diabetes and hypertension, and the use of ACE inhibitors and/or angiotensin II receptor antagonists are recommended in order to prevent or slow the risk of recurrence.
(Evidence level C)